You have no items in your shopping cart.
On Promotion
Category
Tested Applications
Reactivity
Conjugation
Biologically Active
Featured Product
Search results for: 'recombinant'
Unconjugated
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 48.3 KDa. Observed: 55-60 KDa, reducing conditions
Human
Gln21-Asn203
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 85.6 KDa. Observed: 90-120 KDa, reducing conditions
Human
Val20-Thr547
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 78.5 KDa. Observed: 95-120 KDa, reducing conditions
Human
Val19-Ser482
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 14.6 KDa. Observed: 25-35 KDa, reducing conditions
Human
Tyr17-Thr135
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 99.3 KDa. Observed: 115-125 KDa, reducing conditions
Mouse
Ala21-Gly664
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 41.1 KDa. Observed: 42-58 KDa, reducing conditions
Mouse
Tyr20-Glu140
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 45.6 KDa. Observed: 55-70 KDa, reducing conditions
Human
Gln67-Ser225
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 74 KDa. Observed: 90-95 KDa, reducing conditions
Human
Val18-Leu680
C-6His
1 mg, 10 μg, 50 μg, 500 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 36.4 KDa. Observed: 32-50 KDa, reducing conditions
Mouse
His18-Phe339
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 52.2 KDa. Observed: 80-110 KDa, reducing conditions
Human
Gln67-Ala528
C-6His
10 μg, 50 μg, 500 μg, 1 mg